ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Outcomes of Benefit Reassessments of Orphan Drugs in Germany After Exceedance of the Lowered Sales Threshold of 30 Million Euros
Nov 19, 2024, 10:30 AM
«
1861
1862
1863
1864
1865
1866
(current)
1867
1868
1869
1870
»